Medicare Enrolled
Dr. Joseph Abboud, M.D.
Pulmonary Disease · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abboud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abboud?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abboud
Dr. Joseph Abboud is a pulmonary disease specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Abboud performed 3,257 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Abboud received a total of $41,930 from 70 pharmaceutical and/or device companies across 534 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abboud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in PA
$41,930 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,257
Medicare services
Top 3% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
830 | $174 | $370 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
559 | $31 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
415 | $99 | $219 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
215 | $41 | $148 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
211 | $138 | $268 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
193 | $88 | $183 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
98 | $15 | $53 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
90 | $20 | $46 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $142 | $313 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
85 | $45 | $161 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
78 | $98 | $229 |
| New patient office visit, complex (60-74 min) | 75 | $174 | $305 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
74 | $8 | $33 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
60 | $22 | $44 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
57 | $9 | $25 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
42 | $14 | $25 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
30 | $36 | $73 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
20 | $94 | $160 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
19 | $71 | $409 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
19 | $28 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$41,930
Total received (2018-2024)
Avg $5,990/year across 7 years
Top 8% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
534
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$28,806
2023
$3,345
2022
$2,136
2021
$1,106
2020
$1,070
2019
$2,784
2018
$2,684
Payments by company (2024)
Stryker Corporation
$25,090
AstraZeneca Pharmaceuticals LP
$752
GlaxoSmithKline, LLC.
$498
United Therapeutics Corporation
$326
GENZYME CORPORATION
$263
Mylan Specialty L.P.
$211
Insmed, Inc.
$187
Harmony Biosciences Llc
$136
HARMONY BIOSCIENCES LLC
$134
Regeneron Healthcare Solutions, Inc.
$104
Mallinckrodt Hospital Products Inc.
$95
Actelion Pharmaceuticals US, Inc.
$89
Tactile Systems Technology Inc
$82
Alexion Pharmaceuticals, Inc.
$75
Philips North America LLC
$73
Amgen Inc.
$73
ZOLL Respicardia, Inc.
$71
Axsome Therapeutics, Inc.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$56
Zimmer Biomet Holdings, Inc.
$48
ABBVIE INC.
$44
Avadel CNS Pharmaceuticals, LLC
$43
E.R. Squibb & Sons, L.L.C.
$40
Pulmonx Corporation
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Genentech USA, Inc.
$26
Inspire Medical Systems, Inc.
$25
La Jolla Pharmaceutical Company
$24
Bayer Healthcare Pharmaceuticals Inc.
$22
Electromed, Inc.
$21
Resmed Corp
$21
Grifols USA, LLC
$15
Astellas Pharma US Inc
$15
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 91.4% of 2024 payments
All-time payments by company (2018-2024) ›
Stryker Corporation
$25,491
AstraZeneca Pharmaceuticals LP
$2,415
GlaxoSmithKline, LLC.
$1,897
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,346
Insmed, Inc.
$721
GENZYME CORPORATION
$594
Mylan Specialty L.P.
$585
Genentech USA, Inc.
$560
Actelion Pharmaceuticals US, Inc.
$510
Zimmer Biomet Holdings, Inc.
$507
Flexion Therapeutics, Inc.
$491
ENCORE MEDICAL, LP
$446
Regeneron Healthcare Solutions, Inc.
$385
Amgen Inc.
$334
United Therapeutics Corporation
$326
Boston Scientific Corporation
$313
Janssen Pharmaceuticals, Inc
$265
Janssen Scientific Affairs, LLC
$238
Alexion Pharmaceuticals, Inc.
$237
BOSTON SCIENTIFIC CORPORATION
$234
Philips Electronics North America Corporation
$223
Grifols USA, LLC
$212
Axsome Therapeutics, Inc.
$203
Takeda Pharmaceuticals U.S.A., Inc.
$161
Respicardia, Inc.
$157
Inspire Medical Systems, Inc.
$147
Paratek Pharmaceuticals, Inc.
$141
Otsuka America Pharmaceutical, Inc.
$139
Harmony Biosciences Llc
$136
Abbott Laboratories
$135
HARMONY BIOSCIENCES LLC
$134
E.R. Squibb & Sons, L.L.C.
$131
Amarin Pharma Inc.
$124
IMPULSE DYNAMICS (USA) INC.
$123
Harmony Biosciences LLC
$120
Mallinckrodt Hospital Products Inc.
$119
Sunovion Pharmaceuticals Inc.
$119
ANI Pharmaceuticals, Inc.
$106
Merck Sharp & Dohme LLC
$93
Tactile Systems Technology Inc
$82
JAZZ PHARMACEUTICALS INC.
$81
Baxter Healthcare
$78
Electromed, Inc.
$77
Philips North America LLC
$73
ZOLL Respicardia, Inc.
$71
AbbVie Inc.
$71
ABBVIE INC.
$64
Allergan Inc.
$55
Mallinckrodt LLC
$54
Globus Medical, Inc.
$54
Nestle HealthCare Nutrition Inc.
$50
PFIZER INC.
$48
Mallinckrodt Enterprises LLC
$48
Avadel CNS Pharmaceuticals, LLC
$43
Resmed Corp
$43
Pulmonx Corporation
$37
PORTOLA PHARMACEUTICALS, LLC
$29
Phadia US Inc.
$27
Inogen, Inc.
$27
La Jolla Pharmaceutical Company
$24
IDORSIA PHARMACEUTICALS US INC
$22
Bayer Healthcare Pharmaceuticals Inc.
$22
Vapotherm Inc
$21
Bayer HealthCare Pharmaceuticals Inc.
$20
Allergan, Inc.
$18
Medtronic Vascular, Inc.
$18
Lilly USA, LLC
$17
Astellas Pharma US Inc
$15
Nabriva Therapeutics, plc
$14
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 71.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AEQUALIS PERFORM · AIRSENSE · AIRSUPRA · AMPLATZER Occluders · ANDEXXA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AVYCAZ · Adempas · Aimovig · Anthem · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BROVANA · CAMZYOS · CHANTIX · CHARTIS CATHETER · CINQAIR · CYRAMZA · Comprehensive Shoulder System · Cresemba · DJO Surgical AltiVate Anatomic System · DUPIXENT · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · FORCE FIBER · Flexitouch Plus · GIAPREZA · GLASSIA · General - EP · Hillrom - Life 2000 Ventilation System · ICONIX · IMFINZI · INOGEN ONE G3 OXYGEN CONCENTRATOR · INSPACE · INSPIRE · ImmunoCAP · JARDIANCE · JYNARQUE · LONHALA MAGNAIR · LUMRYZ · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER SMART SYSTEM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Precision Flow · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · Repatha · Respiratoriy Care Undiv · Reveal LINQ · SAMSCA · SMARTVEST · SPIRIVA RESPIMAT · STELARA · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEFLARO · TEZSPIRE · TORNIER PERFORM REVERSED AUGMENTED GLENOID · TRELEGY ELLIPTA · TYVASO · Tricera Handpiece · Trilogy 100 · ULTOMIRIS · UPTRAVI · Ultomiris · Utibron · Vascepa · WAKIX · WATCHMAN · WATCHMAN FLX · Wakix · Wellcentive Undiv · XARELTO · XYREM · XYWAV · Xenleta · Xofluza · Xolair · YUPELRI · Yupelri · ZENPEP · ZERBAXA · Zilretta · inCourage · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
257
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abboud is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abboud experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Abboud performed 830 critical care, first 30-74 min services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Abboud receive payments from pharmaceutical companies?
Yes. Dr. Abboud received a total of $41,930 from 70 companies across 534 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abboud's costs compare to other pulmonary diseases in Bryn Mawr?
Dr. Abboud's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abboud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Bryn Mawr
Browse pulmonary diseases in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology